Related Experiment Video
Updated: Jan 18, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2
Chi Zhang1, Xi Huang2, Cheng Hu1
1Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
U2AF homology motif kinase 1 (UHMK1) drives prostate cancer progression by activating methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) through a positive feedback loop. Targeting this UHMK1-MTHFD2 axis offers a potential therapeutic strategy for prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- U2AF homology motif kinase 1 (UHMK1) is implicated in RNA processing and protein phosphorylation, influencing tumor progression.
- Its role in human prostate cancer (PCa) warrants further investigation into its regulatory mechanisms and biological functions.
Purpose of the Study:
- To explore the regulatory mechanisms and biological functions of UHMK1 in prostate cancer.
- To evaluate the expression and prognostic significance of UHMK1 in PCa.
- To investigate the molecular pathways driving UHMK1 activity in PCa.
Main Methods:
- Systematic evaluation of UHMK1 expression and prognostic significance in public databases.
- Immunohistochemistry (IHC) validation in PCa specimens.
- In vitro and in vivo gain-of-function and loss-of-function experiments.
- Molecular and biochemical assays to determine UHMK1 regulatory mechanisms.
Main Results:
- UHMK1 is significantly upregulated in PCa tissues, correlating with poor prognosis.
- UHMK1 depletion suppresses, while overexpression promotes, PCa cell proliferation and metastasis.
- UHMK1 phosphorylates NCOA3, activating ATF4 and upregulating MTHFD2 transcription.
- MTHFD2 reciprocally enhances UHMK1 expression, forming a positive feedback loop.
Conclusions:
- The UHMK1-MTHFD2 axis forms a positive feedback loop driving PCa progression.
- Targeting this axis presents a promising therapeutic strategy for prostate cancer.
- Understanding this pathway could lead to novel treatments for PCa.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades

